Tag Archives: China

FiercePharmaAsia—AZ’s China business; BeiGene CEO’s $28M pay; Kangmei’s $4.4B accounting error

AstraZeneca warned of slowing China growth after it lost a major government procurement deal for Crestor to a generic drugmaker. BeiGene’s CEO nabbed a $ 15 million special equity award in 2018 and ranked as biopharma’s second-highest-paid exec for the year. China’s Kangmei Pharma saw shares plummet on news that its shares could be delisted after a $ 4.4 billion accounting “error.” 1.… Read More »

Harvard research reveals Coke’s fingerprints on health policy in China

A complex network of research funding, institutional ties, and personal influence allowed Coca-Cola, through connections with a nonprofit group, to exert substantial influence over obesity science and policy solutions in China, nudging government policy into alignment with the company’s corporate interests, a Harvard study has found. Professor Susan Greenhalgh’s study reveals not just efforts by… Read More »